Home
Contact us
Locations
Site Map
English
Ελληνικά
username
password
General
History
Mission
Structure
Personnel
General
R & D Generics
R & D API
General
Pharmaceutical Products
Cosmetic
Licensing Opportunities
Agency Agreements
Partners
General
Products
Sales Reps
Distribution
General
Quality Assurance
Regulatory Affairs
Quality Control
Production
Latest News
Press
Publications & Patents
Conferences
Research Collaborations
Sponsorships
Career opportunities
print friendly
Ovapac
Active Ingredient
Paclitaxel
Therapeutic Target
Antimicrotubule agent - Cancer
Ovapac's Specifications
Form
Strength
Package
Sol. Inj. IV/INF
30 mg/5ml
1 vial
Sol. Inj. IV/INF
100 mg/16,7ml
1 vial
For more information click here (PDF format)
A-cnotren
Adicanil
Aurid
Azapin
Belifax
Calci-10
Delitroxin
Dinalexin
Farbovil
Labilex
Ladinin
Lebilon
Lanomycin
Lostin
Nelabocin
Nimovac-V
Ovapac
Nolvac
Seproc
Stabilanol
home
/
Sales and Marketing - Greece
/
Products
/
Ovapac
Copyright 2006
Pharmathen Pharmaceuticals S.A.
Powered by
eRational S.A.